New Kyowa Hakko Kirin President Steeped In Antibody Drug Research
This article was originally published in PharmAsia News
Executive Summary
Kyowa Hakko Kirin’s new president is considered an expert researcher of antibodies, reflecting the drug maker’s market focus.